menu
    • menu

    Company profile for Oruka Therapeutics

    NEW Drugs in Dev: 6
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oruka Therapeutics is dedicated to pioneering innovative biologics to revolutionize the treatment landscape for individuals battling chronic skin conditions. At Oruka, our proprietary portfolio targets the fundamental mechanisms underlying plaque psoriasis, psoriatic arthritis, and various other dermatologic and inflammatory conditions. The investigational therapies we're developing are meticulously designed to provide patient...
    Oruka Therapeutics is dedicated to pioneering innovative biologics to revolutionize the treatment landscape for individuals battling chronic skin conditions. At Oruka, our proprietary portfolio targets the fundamental mechanisms underlying plaque psoriasis, psoriatic arthritis, and various other dermatologic and inflammatory conditions. The investigational therapies we're developing are meticulously designed to provide patients suffering from chronic skin diseases with unparalleled relief, aiming for exceptionally high rates of complete disease clearance.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oruka TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Waltham, MA 02453
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.orukatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oruka-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oruka Therapeutics Reports Q4, Full-Year 2025 Results
    Oruka Therapeutics Reports Q4, Full-Year 2025 Results

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255109/0/en/Oruka-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Oruka Therapeutics Joins Multiple Upcoming Conferences
    Oruka Therapeutics Joins Multiple Upcoming Conferences

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234400/0/en/Oruka-Therapeutics-to-Participate-in-Multiple-Upcoming-Conferences.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Oruka Reports Positive ORKA-002 Data, Initiates EVERLAST-B Trial
    Oruka Reports Positive ORKA-002 Data, Initiates EVERLAST-B Trial

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216715/0/en/Oruka-Therapeutics-Announces-Positive-Interim-Phase-1-Data-for-ORKA-002-and-Initiation-of-EVERLAST-B-Trial-of-ORKA-001.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Oruka Therapeutics Presents at 44th JPM Healthcare Conference
    Oruka Therapeutics Presents at 44th JPM Healthcare Conference

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213454/0/en/Oruka-Therapeutics-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Oruka Therapeutics Reveals Board Member Addition & Transition
    Oruka Therapeutics Reveals Board Member Addition & Transition

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3204286/0/en/Oruka-Therapeutics-Announces-New-Board-Member-and-Board-Transition.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    Oruka Therapeutics Unveils Q3 2025 Financials & Corporate Update
    Oruka Therapeutics Unveils Q3 2025 Financials & Corporate Update

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186800/0/en/Oruka-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search